Key Metrics
CiteScore 

4.2
H-Index 

94
Impact Factor 

< 5
SJR 

Q2Biotechnology

SNIP 

0.74
Recommended pre-submission checks
Powered by 

Topics Covered on Current Pharmaceutical Biotechnology
Current Pharmaceutical Biotechnology Journal Specifications
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2000 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Pharmaceutical Biotechnology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Current Pharmaceutical Biotechnology
Protection of Fulvic Acid Against 5-Fluorouracil-induced Intestinal Injury in Mice.
- 27 Jul 2026
- Current pharmaceutical biotechnology
Phytochemicals as Novel Antifungal Agents Against Candida species.
- 25 Jul 2026
- Current pharmaceutical biotechnology
Ultraviolet-A-Enhanced Antibacterial Activities on Gentamicin-Resistant Escherichia coli by Silver Nanorods Synthesized from Callistemon viminalis Leaf Extract.
- 23 Jul 2026
- Current pharmaceutical biotechnology
Challenges and Strategies in Advancing miRNA-based Cancer Therapeutics.
- 22 Jul 2026
- Current pharmaceutical biotechnology
Evaluation of In vitro Antibacterial Efficacy of Terminalia catappa Leaf Extracts: A Selective Killing Approach for Disease Management in Recirculatory Aquaculture System.
- 22 Jul 2026
- Current pharmaceutical biotechnology
SIRT6, a New Hope in Liver Diseases: From Pathogenic Mechanisms to Therapeutic Strategies.
- 22 Jul 2026
- Current pharmaceutical biotechnology
Protection of Fulvic Acid Against 5-Fluorouracil-induced Intestinal Injury in Mice.
- 27 Jul 2026
- Current pharmaceutical biotechnology
Phytochemicals as Novel Antifungal Agents Against Candida species.
- 25 Jul 2026
- Current pharmaceutical biotechnology
Ultraviolet-A-Enhanced Antibacterial Activities on Gentamicin-Resistant Escherichia coli by Silver Nanorods Synthesized from Callistemon viminalis Leaf Extract.
- 23 Jul 2026
- Current pharmaceutical biotechnology
Challenges and Strategies in Advancing miRNA-based Cancer Therapeutics.
- 22 Jul 2026
- Current pharmaceutical biotechnology
Evaluation of In vitro Antibacterial Efficacy of Terminalia catappa Leaf Extracts: A Selective Killing Approach for Disease Management in Recirculatory Aquaculture System.
- 22 Jul 2026
- Current pharmaceutical biotechnology
SIRT6, a New Hope in Liver Diseases: From Pathogenic Mechanisms to Therapeutic Strategies.
- 22 Jul 2026
- Current pharmaceutical biotechnology
FAQs on Current Pharmaceutical Biotechnology
How long has Current Pharmaceutical Biotechnology been actively publishing? 
What is the publishing frequency of Current Pharmaceutical Biotechnology? 
How many articles did Current Pharmaceutical Biotechnology publish last year? 
What is the eISSN & pISSN for Current Pharmaceutical Biotechnology? 
What is Citescore for Current Pharmaceutical Biotechnology? 
What is the H Index for Current Pharmaceutical Biotechnology ? 
What is SNIP score for Current Pharmaceutical Biotechnology? 
What is the SJR for Current Pharmaceutical Biotechnology? 
Who is the publisher of Current Pharmaceutical Biotechnology? 
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary